
News|Slideshows|October 12, 2022
Cardiometabolic Disease Update: 12 Studies
Studies of cardiometabolic disease pathophysiology, prevention, and treatment make science news every day. Find 12 here, at-a-glance.
Advertisement
Less than 7% of the US population has optimal cardiometabolic health according to a novel study that assessed 5 key components of the measure. That disappointing metric and others like it have fueled a surge in research into cardiometabolic disease pathophysiology, prevention, and treatment.
Click through the 12 slides in this update for an at-a-glance overview of 2022's most promising cardiometabolic research to date.
CKD, Heart Failure, Hypertension, MACE, NAFLD/NASH, Type 2 Diabetes
Newsletter
Enhance your clinical practice with the Patient Care newsletter, offering the latest evidence-based guidelines, diagnostic insights, and treatment strategies for primary care physicians.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Patient Care Online
1
FDA Clears Prescription Digital Therapeutic LumosityRx for Adults with ADHD
2
Dupilumab Shows Higher 2-Year Drug Survival Than Other Targeted Therapies for Atopic Dermatitis
3
Alzheimer Diseae Drug Development Shifts as Tau Antibody Research Falters
4
FDA Approves First Self-Administered Nasal Spray for Adults with PSVT, Milestone Pharmaceuticals Reports
5

















































































































































































































































































